ETG Siedlce - PPDS

Siedlce, Masovian Voivodeship 08-110

0 studies enrolling now · 3 studies all time

What they study most

Plaque Psoriasis, Sjogren Disease

Studies at this site

• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed